About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 299 record(s)
Req # A-2021-000060
Adverse Reaction Report (AER) for Dexilant. Report number: 000934154. (ADR) for Vedolizumab. Report number: 000933837. (ADRs) for Ondansetron. Report numbers: E2B_03663702, 000933934, 000933444. (ADRs) for Pantoprazole Sodium. Report numbers:…Organization: Health Canada
August 2021
Req # A-2021-000089
Adverse Drug Reaction (ADR) for ZOPICLONE. Report number: 000929090.Organization: Health Canada
August 2021
Req # A-2021-000110
Adverse Reaction Reports (AERs). Report numbers: E2B_03567247, E2B_03589833, E2B_03590102, E2B_03600987, E2B_03611575, E2B_03612267, E2B_03614117, E2B_03623643, E2B_03624058, E2B_03642937, E2B_03643408, E2B_03643537, E2B_03645999, E2B_03646412,…Organization: Health Canada
August 2021
Req # A-2021-000112
Adverse Reaction Reports (AERs). Report numbers: E2B_03670882, E2B_03671113, E2B_03673085, E2B_03673787, E2B_03676653, E2B_03679087, E2B_03683446, E2B_03688642, E2B_03689833, E2B_03689871, E2B_03694778, E2B_03702669, E2B_03703323, E2B_03706111,…Organization: Health Canada
August 2021
Req # A-2021-000193
Adverse Reaction Reports (AERs). Report numbers: 000936333, E2B_03710778, E2B_03719424, E2B_03722579, E2B_03747388.Organization: Health Canada
August 2021
Req # A-2021-000198
Adverse Reaction Reports (AERs) for Zostavax. Report numbers: 000705440, 000705544, 000705797, 000705816, 000706538, 000706555, 000707008, 000707901, 000710452.Organization: Health Canada
August 2021
Req # A-2021-000240
Adverse Reaction Reports (AERs) for RIFAMPICIN. Report numbers: E2B_03399414, E2B_03400260, 000922713, E2B_03589947, 000930786.Organization: Health Canada
August 2021
Req # A-2021-000241
Adverse Drug Reaction (ADR) for RIFAMPICIN. Report number: E2B_03561828.Organization: Health Canada
August 2021
Req # A-2021-000244
Adverse Reaction Reports (AERs) for Naltrexone. Report numbers: 000921136, 000936225. (ADR) for Hydromorphone. Report number: 000937189. (ADRs) for Heparin. Report numbers: E2B_03749383, 000918034, 000918051.Organization: Health Canada
August 2021
Req # A-2021-000249
Adverse Reaction Reports (AERs) for Nitroglycerin. Report numbers: E2B_03687020, E2B_03564299.Organization: Health Canada
August 2021